PLUS THERAPEUTICS, INC.·4

Sep 12, 4:30 PM ET

Sims Andrew John Hugh MacIntyre 4

4 · PLUS THERAPEUTICS, INC. · Filed Sep 12, 2024

Insider Transaction Report

Form 4
Period: 2024-09-11
Sims Andrew John Hugh MacIntyre
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-09-11+46,07446,074 total
    Exercise: $1.26Exp: 2034-09-11Common Stock (46,074 underlying)
Footnotes (1)
  • [F1]The options vest over four years in equal 1/48th increments on each monthly anniversary of the issuance date, and vest upon a change of control event in accordance with the Reporting Person's employment agreement.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4